Frances Mosley is a corporate associate in the Menlo Park and San Diego offices of Kilpatrick Townsend. Her practice focuses on private companies in start-up and venture capital law, with an emphasis on medical device, life science, clean energy and technology companies. Ms. Mosley represents emerging growth companies on general corporate and securities matters, including formation and operation, venture capital financing, strategic investments and debt transactions, mergers and acquisitions, and day-to-day corporate governance matters, including advice on board, advisor, and employment matters. Ms. Mosley’s experience also includes Securities and Exchange Commission filings and compliance.
Ms. Mosley has been recognized by Super Lawyers Magazine as a Rising Star in Corporate Law each year from 2014-2017.
Represented the founders of Editas Medicine, Incorporated in a $43 million Series A Financing to fund the collaborative research and development by a team of world-class scientists to develop a method of "editing out" abnormalities in genes in human cells.
Represented MVRx in $6 million Series A financing.
Represented Q Bio in $7 million Series Seed financing.
Represented lead investors in $40 million Series C financing of Hyperfine Research, Inc.
Insights View All
University of California, Hastings College of the Law, J.D.
CALI & Witkin Award for Academic Excellence
Executive Notes Editor, UC Hastings Business Law Journal
University of San Francisco, B.A., Political Science, Minors in Legal Studies and Public Service (2005) summa cum laude, Pi Sigma Alpha
Asian Pacific American Bar Association of Silicon Valley, Member
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.